Chardan Capital Reiterates Buy on Senti Biosciences, Maintains $6 Price Target
BenzingaAug 15, 2023 04:25 ET
Senti Biosciences Analyst Ratings
BenzingaAug 15, 2023 04:23 ET
Chardan Capital Maintains Buy on Senti Biosciences, Lowers Price Target to $6
BenzingaMay 11, 2023 13:08 ET
Morgan Stanley Adjusts Price Target on Senti Biosciences to $2 From $3, Keeps Equalweight Rating
MT NewswiresMar 24, 2023 09:25 ET
Morgan Stanley Maintains Equal-Weight on Senti Biosciences, Lowers Price Target to $2
BenzingaMar 24, 2023 08:44 ET
Morgan Stanley Reaffirms Their Hold Rating on Senti Biosciences (SNTI)
TipRanksMar 24, 2023 06:31 ET
Chardan Adjusts Price Target on Senti Biosciences to $7 From $8, Keeps Buy Rating
MT NewswiresMar 23, 2023 08:26 ET
Chardan Capital Maintains Buy on Senti Biosciences, Lowers Price Target to $7
BenzingaMar 23, 2023 08:14 ET
Chardan Adjusts Senti Biosciences' Price Target to $8 From $12, Keeps Buy Rating
MT NewswiresJan 30, 2023 06:57 ET
Senti Biosciences Analyst Ratings
Benzinga Analyst RatingsJan 30, 2023 05:38 ET
Senti Biosciences (SNTI) Receives a Buy From Bank of America Securities
TipRanksJan 30, 2023 03:00 ET
Senti Biosciences (SNTI) Receives a Buy From Chardan Capital
TipRanksJan 27, 2023 13:58 ET
Morgan Stanley Maintains Equal-Weight on Senti Biosciences, Lowers Price Target to $3
Benzinga Real-time NewsJan 27, 2023 10:35 ET
Senti Biosciences Analyst Ratings
Benzinga Analyst RatingsJan 27, 2023 10:30 ET
Senti Biosciences Analyst Ratings
Benzinga Analyst RatingsDec 16, 2022 10:12 ET
Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK) and Senti Biosciences (SNTI)
TipRanksNov 11, 2022 08:10 ET
Senti Biosciences Analyst Ratings
Benzinga Analyst RatingsOct 7, 2022 06:13 ET
Morgan Stanley Initiates Coverage On Senti Biosciences With Equal-Weight Rating, Announces Price Target of $7.5
Benzinga Real-time NewsOct 7, 2022 06:12 ET
BofA Securities Starts Senti Biosciences at Buy With $7 Price Target
MT NewswiresSep 29, 2022 07:54 ET
Senti Biosciences Analyst Ratings
Benzinga Analyst RatingsSep 29, 2022 07:22 ET
No Data
No Data